Zhejiang Huaye Plastics Machinery
301616
Alnera Aluminium
301613
Glory View Technology
301396
Guangzhou Sie Consulting
300687
Tibet Duo Rui Pharmaceutical
301075
CN Stock MarketDetailed Quotes
688373 Shanghai Micurx Pharmaceutical
- 5.79
- -0.20-3.34%
Market Closed Mar 31 15:00 CST
3.80BMarket Cap-8.62P/E (TTM)
6.05High5.65Low103.84KlotVolume6.00Open5.99Pre Close60.16MTurnover2.84%Turnover RatioLossP/E (Static)655.61MShares6.6952wk High8.64P/B2.12BFloat Cap3.6852wk Low7.19Limit Up366.05MShs Float14.20Historical High4.79Limit Down6.68%Amplitude3.23Historical Low--Dividend TTM5.79Avg Price58.37KlotAsk--Div YieldTTM100Lot Size43.02KlotBid
Shanghai Micurx Pharmaceutical Key Stats
All
YOY
| (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | 49.38%136.56M | 41.03%98.7M | 60.23%64.12M | 63.19%32.57M | 102.74%91.42M | 131.25%69.99M | 145.98%40.01M | 119.97%19.96M | 465.29%45.09M | 528.57%30.26M |
| Refunds of taxes and levies | ---- | -99.24%97.88K | -99.24%97.88K | -99.24%97.88K | 74.85%12.84M | 72.30%12.84M | 72.30%12.84M | --12.84M | --7.34M | --7.45M |
| Cash received relating to other operating activities | -6.34%3.58M | -0.74%3.2M | 14.24%2.47M | -43.03%936.26K | -81.32%3.83M | -65.44%3.23M | -27.17%2.16M | -18.51%1.64M | -46.50%20.48M | -70.91%9.34M |
| Cash inflows from operating activities | 29.66%140.15M | 18.53%102.01M | 21.20%66.68M | -2.44%33.6M | 48.23%108.09M | 82.87%86.06M | 106.16%55.02M | 210.59%34.44M | 57.63%72.92M | 27.45%47.06M |
| Goods services cash paid | 31.41%415.61M | 28.41%273.81M | 69.23%203.17M | 74.44%93.19M | 46.43%316.26M | 44.20%213.24M | 71.56%120.06M | 21.53%53.42M | 46.43%215.98M | 45.24%147.88M |
| Staff behalf paid | 5.44%111.02M | -0.77%78.43M | 7.65%58.16M | 11.19%32.92M | 18.78%105.29M | 14.84%79.03M | 17.99%54.02M | 22.25%29.61M | 25.05%88.64M | 27.76%68.82M |
| All taxes paid | 807.41%27M | 1,383.36%27.51M | 2,415.26%25.45M | 1,183.37%4.35M | 2,000.57%2.98M | 1,113.86%1.85M | 562.35%1.01M | 915.28%338.89K | -63.21%141.66K | -55.88%152.78K |
| Cash paid relating to other operating activities | 166.49%33.71M | -5.81%15.74M | -23.28%8.92M | 21.73%3.87M | 54.95%12.65M | 83.10%16.71M | 366.64%11.63M | 28.57%3.18M | -3.69%8.16M | 21.85%9.13M |
| Cash outflows from operating activities | 34.35%587.33M | 27.23%395.49M | 58.37%295.7M | 55.21%134.33M | 39.70%437.17M | 37.55%310.84M | 57.69%186.72M | 22.45%86.55M | 37.71%312.93M | 38.20%225.98M |
| Net cash flows from operating activities | -35.89%-447.18M | -30.57%-293.49M | -73.89%-229.02M | -93.31%-100.73M | -37.11%-329.08M | -25.63%-224.78M | -43.58%-131.7M | 12.56%-52.11M | -32.61%-240.01M | -41.34%-178.92M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | -23.10%2.99B | -37.32%1.86B | -40.47%1.23B | -36.55%633.45M | 159.31%3.88B | 256.15%2.97B | 202.78%2.07B | 173.53%998.4M | -17.64%1.5B | -47.29%835M |
| Cash received from returns on investments | -45.55%20.17M | 39.56%40.58M | -17.20%15.83M | 46.34%12.62M | 149.39%37.05M | 375.12%29.08M | 274.58%19.12M | 240.92%8.62M | 46.98%14.86M | -23.22%6.12M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | --27.46K | --28K | --28K | ---- | ---- | ---- | ---- | ---- | --1.5M | --1.5M |
| Cash inflows from investing activities | -23.31%3.01B | -36.57%1.9B | -40.26%1.25B | -35.84%646.07M | 158.95%3.92B | 256.38%3B | 203.25%2.09B | 173.89%1.01B | -17.20%1.51B | -47.07%842.62M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -88.06%914.77K | -99.25%48K | -99.20%48K | -98.68%48K | -37.09%7.66M | -31.92%6.42M | 59.98%6.01M | 319.68%3.63M | -46.86%12.18M | -4.31%9.43M |
| Cash paid to acquire investments | -30.38%2.49B | -42.74%1.57B | -41.47%1.05B | -47.67%488.19M | 60.10%3.58B | 94.01%2.73B | 274.55%1.8B | 200.92%932.84M | 25.32%2.24B | 2.54%1.41B |
| Cash paid relating to other investing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --5.9M |
| Cash outflows from investing activities | -30.51%2.49B | -42.87%1.57B | -41.66%1.05B | -47.86%488.24M | 59.57%3.59B | 92.37%2.74B | 268.39%1.8B | 201.25%936.47M | 24.40%2.25B | 2.92%1.42B |
| Net cash flows from investing activities | 53.84%514.8M | 29.02%339.49M | -31.52%198.14M | 123.69%157.83M | 145.63%334.63M | 145.24%263.14M | 44.25%289.35M | 24.19%70.56M | -3,404.31%-733.42M | -379.46%-581.61M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | --1.98M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 19,173.99%981.77M | 19,297.14%981.77M |
| Cash from borrowing | 75.00%105M | 66.67%100M | 50.00%60M | -25.00%30M | -59.66%60M | 123.50%60M | 49.00%40M | --40M | 179.35%148.75M | 10.71%26.85M |
| Cash inflows from financing activities | 78.30%106.98M | 66.67%100M | 50.00%60M | -25.00%30M | -94.69%60M | -94.05%60M | 49.00%40M | --40M | 1,837.74%1.13B | 3,341.21%1.01B |
| Borrowing repayment | -71.53%17.02M | -80.46%10.5M | -86.73%7M | -95.81%2M | -14.61%59.77M | 155.89%53.74M | 653.39%52.74M | --47.73M | 623.05%70M | 116.91%21M |
| Dividend interest payment | 42.19%6.54M | 41.60%4.55M | 26.21%2.67M | 22.25%1.2M | 39.45%4.6M | 50.81%3.22M | 31.34%2.11M | 49.75%979.36K | 373.28%3.3M | 732.01%2.13M |
| Cash payments relating to other financing activities | 0.57%15.32M | -3.60%11.02M | -5.38%7.4M | --3.75M | -47.61%15.23M | -51.24%11.43M | 4.22%7.82M | ---- | 43.38%29.08M | 144.42%23.44M |
| Cash outflows from financing activities | -51.16%38.88M | -61.88%26.07M | -72.77%17.07M | -85.75%6.94M | -22.24%79.61M | 46.84%68.38M | 288.95%62.67M | 1,922.91%48.71M | 233.93%102.38M | 138.50%46.57M |
| Net cash flows from financing activities | 447.31%68.09M | 982.10%73.93M | 289.38%42.93M | 364.83%23.06M | -101.91%-19.61M | -100.87%-8.38M | -311.23%-22.67M | -261.60%-8.71M | 3,613.83%1.03B | 9,732.68%962.05M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | -67.80%143.37K | -78.32%-3.39M | -465.81%-1.06M | 43.78%-972.58K | -61.55%445.28K | -214.15%-1.9M | 227.56%290.77K | -2,044.52%-1.73M | 677.94%1.16M | 3,130.67%1.67M |
| Net increase in cash and cash equivalents | 1,098.19%135.86M | 315.18%116.54M | -91.88%10.99M | 888.42%79.18M | -124.36%-13.61M | -86.19%28.07M | 13.01%135.26M | 252.00%8.01M | 142.56%55.88M | 122.66%203.19M |
| Add:Begin period cash and cash equivalents | -9.01%137.48M | -9.01%137.48M | -9.01%137.48M | -9.01%137.48M | 58.69%151.09M | 58.69%151.09M | 58.69%151.09M | 58.69%151.09M | -57.97%95.21M | -57.97%95.21M |
| End period cash equivalent | 98.82%273.33M | 41.78%254.01M | -48.15%148.46M | 36.18%216.66M | -9.01%137.48M | -39.96%179.16M | 33.25%286.35M | 76.89%159.1M | 58.69%151.09M | -6.10%298.4M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | -- | Unqualified opinion | -- | -- | -- | -- | -- |
| Auditor | -- | -- | -- | -- | PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership) | -- | -- | -- | PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
